PEPTIDEREPORT

Research peptide

TB-500

TB-500 appears in online recovery and performance discussions. The site tracks public claims and regulatory references without turning those claims into treatment guidance.

Regulatory watch Last reviewed 2026-06-30 Next review 2026-07-24

Evidence snapshot

Keep this page source-led and refresh it whenever FDA meeting materials or new public regulatory records appear.

Often discussed alongside injury recovery topics.

Scheduled for FDA advisory committee discussion in July 2026.

High risk of overclaiming in generated content.

Tracked claims

TB-500 is commonly grouped with recovery-oriented peptide discussions.

Evidence level: Public discussion / regulatory watch

Sources: U.S. Food and Drug Administration

Avoid implying efficacy unless a specific source supports the precise claim.

The next editorial update should check the FDA advisory committee outcome.

Evidence level: Primary regulatory

Sources: U.S. Food and Drug Administration

Use the date-based review queue to prevent stale regulatory copy.

Sources on this page

Source records are stored in the repo and linked from each claim.

Related compounds

BPC-157

BPC-157 is widely discussed online in injury recovery and performance communities, but the public evidence and regulator...

Regulatory watch

DSIP

DSIP appears in online sleep and recovery discussions. This page tracks the topic as a source-backed index entry pending...

Regulatory watch

Epitalon

Epitalon is often discussed in longevity-oriented peptide content. The page starts as a regulatory watch entry and shoul...

Regulatory watch

KPV

KPV is a peptide topic appearing in online wellness and research discussions. This page tracks the public source record ...

Regulatory watch